Evidence map›Paper›PMID 35463336›Full record

ArticleFrontiers in oncology2022

Efficacy and Biomarker Exploration of Sintilimab Combined With Chemotherapy in the Treatment of Advanced Penile Squamous Cell Carcinoma-A Report of Two Cases.

Xinkuan Mei, Yanyan Zhao, Yiruo Zhang, Jinhua Liao, Chen Jiang, Hesheng Qian, Yingying Du

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Xinkuan MeiDepartment of Oncology, Fuyang Tumor Hospital, Fuyang, China.
Yanyan ZhaoDepartment of Oncology, First Affiliated Hospital of Anhui Medical University, Hefei, China.
Yiruo ZhangDepartment of Oncology, First Affiliated Hospital of Anhui Medical University, Hefei, China.
Jinhua LiaoDepartment of Oncology, Fuyang Tumor Hospital, Fuyang, China.
Chen JiangDepartment of Oncology, Fuyang Tumor Hospital, Fuyang, China.
Hesheng QianDepartment of Oncology, Fuyang Tumor Hospital, Fuyang, China.
Yingying DuDepartment of Oncology, First Affiliated Hospital of Anhui Medical University, Hefei, China.
Fuyang Maternity and Child Health Care Hospital · CNAnhui Medical University · CNFirst Affiliated Hospital of Anhui Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Penile squamous cell carcinoma is a rare malignant tumor of the male reproductive system. We report two cases of advanced penile squamous cell carcinoma with persistent partial response/complete response after sintilimab combined with chemotherapy and analyze the relevant tumor biomarkers.

Indexed as

biomarkerscase reportimmune checkpoint inhibitorspenile cancertumor immune microenvironment

Identifiers

PMID35463336
PMCPMC9021724
OpenAlexW4226119592

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.